These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3792602)

  • 1. Failure of etretinate in epidermodysplasia verruciformis.
    Kowalzick L; Mensing H
    Dermatologica; 1986; 173(2):75-8. PubMed ID: 3792602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of patients with epidermodysplasia verruciformis treated with etretinate.
    Jablonska S; Obałek S; Wolska H
    Dermatologica; 1986; 173(4):196-9. PubMed ID: 3021547
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidermodysplasia verruciformis: Langerhans cells, immunologic effect of retinoid treatment and cytogenetics.
    van Voorst Vader PC; de Jong MC; Blanken R; Kallenberg CG; Vermey A; Scheres JM
    Arch Dermatol Res; 1987; 279(6):366-73. PubMed ID: 3499869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lewandowsky-Lutz epidermodysplasia verruciformis associated with vitiligo].
    Abal'iants LA; Talanin NIu
    Vestn Dermatol Venerol; 1988; (4):63-5. PubMed ID: 3414173
    [No Abstract]   [Full Text] [Related]  

  • 5. [Etretinate and the prevention of skin cancers].
    Verret JL
    Ther Umsch; 1986 Sep; 43(9):699-702. PubMed ID: 3535154
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidermodysplasia verruciformis. Clinical and light- and electron-microscopic observations during etretinate therapy.
    Kanerva LO; Johansson E; Niemi KM; Lauharanta J; Salo OP
    Arch Dermatol Res; 1985; 278(2):153-60. PubMed ID: 3006608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon and retinoid treatment of warts.
    Blanchet-Bardon C; Lutzner MA
    Clin Dermatol; 1985; 3(4):195-9. PubMed ID: 2463864
    [No Abstract]   [Full Text] [Related]  

  • 8. Cimetidine therapy for epidermodysplasia verruciformis.
    Micali G; Nasca MR; Dall'Oglio F; Musumeci ML
    J Am Acad Dermatol; 2003 Feb; 48(2 Suppl):S9-10. PubMed ID: 12582373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermodysplasia verruciformis and human papilloma virus.
    Gewirtzman A; Bartlett B; Tyring S
    Curr Opin Infect Dis; 2008 Apr; 21(2):141-6. PubMed ID: 18317036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermodysplasia verruciformis and generalized verrucosis: the same disease?
    Yanagi T; Shibaki A; Tsuji-Abe Y; Yokota K; Shimizu H
    Clin Exp Dermatol; 2006 May; 31(3):390-3. PubMed ID: 16681585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired epidermodysplasia verruciformis in a child with atopic dermatitis.
    Fernandez KH; Rady P; Tyring S; Stone MS
    Pediatr Dermatol; 2014; 31(3):400-2. PubMed ID: 22938530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermodysplasia verruciformis: unsuccessful therapeutic approach with imiquimod.
    Janssen K; Lucker GP; Houwing RH; van Rijssel R
    Int J Dermatol; 2007 Nov; 46 Suppl 3():45-7. PubMed ID: 17973891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermodysplasia verruciformis: association with isolated IgM deficiency and response to treatment with acitretin.
    Iraji F; Faghihi G
    Clin Exp Dermatol; 2000 Jan; 25(1):41-3. PubMed ID: 10671971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA.
    Weissenborn SJ; Höpfl R; Weber F; Smola H; Pfister HJ; Fuchs PG
    J Invest Dermatol; 1999 Jul; 113(1):122-6. PubMed ID: 10417630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses.
    Boxman IL; Russell A; Mulder LH; Bavinck JN; ter Schegget J; Green A;
    J Invest Dermatol; 2001 Nov; 117(5):1108-12. PubMed ID: 11710920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy.
    Carré D; Dompmartin A; Verdon R; Comoz F; Le Brun E; Freymuth F; Leroy D
    Int J Dermatol; 2003 Apr; 42(4):296-300. PubMed ID: 12694498
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral retinoid treatment of human papillomavirus type 5-induced epidermodysplasia verruciformis.
    Lutzner MA; Blanchet-Bardon C
    N Engl J Med; 1980 May; 302(19):1091. PubMed ID: 6245361
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of epidermodysplasia verruciformis with squamous cell carcinomas on non-sun-exposed areas of skin.
    Ansarin H; Tajziehchi L; Shaianfar N
    Arch Iran Med; 2007 Apr; 10(2):261-3. PubMed ID: 17367237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis.
    Majewski S; Malejczyk J; Jablonska S; Misiewicz J; Rudnicka L; Obalek S; Orth G
    J Am Acad Dermatol; 1990 Mar; 22(3):423-7. PubMed ID: 2155952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis.
    Padlewska K; Ramoz N; Cassonnet P; Riou G; Barrois M; Majewski S; Croissant O; Jablonska S; Orth G
    J Invest Dermatol; 2001 Oct; 117(4):935-42. PubMed ID: 11676835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.